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Abstract
Many stressors elicit changes in corticotrophin (CRH), enkephalin (ENK), and neurotensin (NT) mRNA
levels within the medial parvocellular region of the paraventricular nucleus of the hypothalamus
(mpPVN), and the pattern of changes in mRNA levels appears to depend on the physical
characteristics of the stressor. We questioned whether psychologically distinct stressors would
cause different patterns of neuropeptide mRNA expression within the PVN. Psychologically distinct
stressors were created by employing a paradigm of escapable (controllable) vs non-escapable
(yoked) tail shock. An adult male rats could terminate the stress stimulus by performing wheel-
turning behaviour; his behaviour also terminated the stress for his yoked partner, who had no
control over the termination of the shock. Four h post-stress, brains were collected and processed
for in-situ hybridization histochemistry. Tail-shock stress stimulated a significant increase in CRH,
ENK, and NT mRNA levels within the mpPVN. The number of CRH identified neurones coexpressing
AVP mRNA was also significantly elevated in both stress groups. Moreover, the pattern and
magnitude of the stress-induced increases in mRNA was similar in both stress groups. Additionally,
no stress-induced changes in CRH mRNA levels were observed in the central nucleus of the
amygdala. In sum, two psychologically distinct stressors, escapable vs yoked tail shock stress,
stimulated similar increases in CRH, NT, ENK, and AVP mRNA levels within the mpPVN. These
results suggest that physical attributes of a stress, rather than psychological, may be the more
important factors in determining the PVN mRNA response.
Activation of the hypothalamic-pituitary-adrenal (HPA) axis negative feedback effects of circulating glucocorticoids.
Although CRH is believed to be the primary ACTHcan occur by a wide variety of stressful stimuli. Although the
final outcome of activation of the axis is similar across secretagogue (3), there are other peptides, such as vasopressin
(AVP), that are colocalized with CRH and can act as ACTHstimuli, (i.e. an increase in circulating glucocorticoid concen-
trations), there is evidence to suggest that the central mechan- secretagogues (4). Additional peptides, such as enkephalin
(ENK) and neurotensin (NT), have also been found withinisms by which stressors activate the HPA axis may differ
across stimuli (1,2). Corticosterone secretion from the adrenal the mpPVN and are colocalized with CRH (5–7), although
their role in the regulation of ACTH secretion is still not wellgland is stimulated by release of peptides, primarily cortico-
tropin-releasing-hormone (CRH), from the medial parvo- understood.
Acute stressors do alter the regulation of these peptidescellular region of the paraventricular nucleus of the
hypothalamus (mpPVN). CRH travels through the portal (CRH, AVP, ENK, and NT), and, interestingly, evidence
from many studies suggest that not all stressors affect thevasculature to reach the anterior pituitary and stimulates
adrenocorticotropin-releasing-hormone (ACTH) secretion, regulation of these peptides in the same manner. For example,
Plotsky et al. reported that haemorrhage caused an increasewhich in turn stimulates corticosterone secretion from the
adrenal gland. ACTH secretion is, in part, terminated by in portal blood levels of CRH and AVP (8), while insulin-
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induced hypoglycemia caused an increase in portal blood dexamethasone feedback, can be created in animals using the
escapable/yoked stress paradigm, we asked whether we couldlevels of AVP only (9). CRH mRNA has been reported to
increase after restraint or hypertonic saline injections but not detect differences in the regulation of the HPA axis, specific-
ally the regulation of PVN neuropeptide mRNAs, betweenafter ether (10, 11) or cold stress (11, 12). Conversely, ENK
and NT mRNA levels within the PVN have been reported the two psychologically distinct stress conditions. We chose
to examine the PVN because it represents the final commonto increase after ether stress (10–12) and restraint stress, but
not cold stress (11). path for the flow of information from the central nervous
system to the pituitary, and it has been reported that differentIn addition to being categorized by different physical
properties, stressors can also be categorized by psychological types of stressors can cause differences in neuropeptide
mRNA expression within the mpPVN.features, one of which is the degree to which an animal can
cope with or control the stressor. For example, animals
can cope with stressful events by learning an escape behavi- Results
our, such as a bar press or a wheel turn, to terminate the
stress stimulus. In certain paradigms aimed at testing the Plasma corticosterone levels
effect of controllability, the coping response of a given animal
also terminates the stressor for a yoked partner, who has no Both escapable and yoked tail shock stress stimulated a
marked and sustained increase in plasma corticosterone levelscontrol over the stressor. This results in two animals who
receive the identical amount, duration, and intensity of the (Fig. 1) that did not differ between the two groups. Plasma
corticosterone levels in both stress groups remained elevatedphysical stressor, but differ in the psychological aspect of
controlling or coping with the stressor. A multitude of above the chamber/control group and the home cage group
for the duration of the sampling period. There were noprevious studies have demonstrated that these two stress
conditions have differential effects on a number of parameters significant differences in plasma corticosterone levels between
the two control groups. At the time of decapitation, thealtered by stress. For example, stress-induced analgesia (13),
prolactin secretion (14), gastric ulcer formation (15), catecho- yoked stress group corticosterone levels were slightly elevated
compared to either the chamber/control group or the homelamine system regulation (16), long-term potentiation (17),
and learning of new escape responses (18), are differentially cage control group.
impacted by escapable or non-escapable stressors, with the
less deleterious effects associated with escapable stress. The PVN mRNA Levels
deficit in the learning of a new escape response, or learned
helplessness, caused by the inescapable stress has been well CRH mRNA was readily detectable in the control groups,
and a stress-induced increase in CRH mRNA was observeddocumented. An animal, previously exposed to inescapable
shock, will be unable to learn an appropriate escape response in both the escapable and yoked stress groups. The magnitude
of the CRH mRNA increase was similar in both the escapablewhen placed in a new testing environment.
With regard to the regulation of the HPA axis, most data and yoked stress conditions (Figs 2, 3).
In the control animals, ENK mRNA was found within thesuggest that these two psychologically distinct stress condi-
tions stimulate similar patterns of ACTH and corticosterone ventral tail of the parvocellular division of the PVN. After
secretion (19, 20; cf 21). However, the ability of the synthetic
glucocorticoid dexamethasone to suppress stress-induced
corticosterone secretion is dependent on stress controllability,
with normal suppression observed in the rats capable of
escaping their stress, and incomplete dexamethasone suppres-
sion observed in their yoked partners (22; and unpublished
data). These results suggest that mechanisms regulating the
HPA axis may be different between these two stress
conditions.
The impact of psychologically distinct stressors on the
regulation of the HPA axis is of particular interest given the
interrelationship between stressful life events and clinical
depression (23, 24), and the dysregulation of the HPA axis
that often occurs in clinical depression. Almost all depressed
patients have an increased drive to the HPA axis (25), and
#50% of patients have impaired glucocorticoid negative
feedback, as assessed by the dexamethasone suppression test
(26). Depressed patients also have an increase in the number
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of CRH neurones within the PVN (27) and in the number F. 1. Mean (±SEM) plasma corticosterone levels measured from 0 to
150 min after termination of stress. Escapable or yoked stress groupsof PVN CRH neurones containing AVP (28). Moreover, it
received 100 1.0 mA shocks delivered 30–90 s apart, with an averagehas been proposed that depressed patients may hypersecrete
intertrial interval of 60 s. Chamber controls were placed in the shockAVP as a result of impaired glucocorticoid feedback (29). apparatus but did not receive any shock, and home cage controls
Because some of the same characteristics observed in remained in their cages for the duration of the experiment. Animals were
decapitated 480 min after termination of stress for tissue collection.depressed patients, such as learned helplessness and faulty
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F. 2. Photomicrograph illustrating CRH (row A), ENK (row B) or NT (row C) mRNA levels within the PVN of a home cage control animal ( left
column), an animal exposed to yoked tail shock stress (centre column), and an animal exposed to escapable tail shock stress (right column).
either escapable or yoked tail-shock stress, there was an mRNA levels within the medial parvocellular division of the
PVN. Again, the stimulated increase in NT mRNA wasoverall increase in ENK mRNA levels within the PVN, with
signal now readily detectable within the medial parvocellular similar between both stress conditions (Figs 2, 3).
Double in-situ hybridization techniques were used to deter-division of the PVN. There was no difference in the pattern
or magnitude of this increase in ENK mRNA levels between mine the number of AVP expressing CRH neurones within
the mpPVN. In control conditions, very few neurones werethe escapable or yoked stress conditions (Figs 2, 3).
Within the parvocellular region of the PVN, NT mRNA positively identified as containing both CRH and AVP
mRNA. After tail shock stress, there was no change in thelevels were very low in control animals. Tail-shock stress,
either escapable or yoked, stimulated an increase in NT number of CRH-dig labelled neurones. However, there was
© 1999 Blackwell Science Ltd, Journal of Neuroendocrinology, 11, 121–128
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CeA CRH mRNA
CRH mRNA was also measured within the central nucleus
of the amygdala (CeA). Neither stress condition altered CRH
mRNA levels within the CeA. CRH mRNA levels (integrated
optical density measurements) were: home cage controls
7460.83±976.16; yoked stress group 8954.67±829.23; escap-
able stress group 8272.86±507.6.
Discussion
In the current study, we examined changes in PVN mRNA
levels after either escapable or yoked tail shock stress. We
found that tail-shock stress, either escapable or yoked, stimu-
lated an increase in the expression of CRH, ENK, and NT
mRNA levels within the parvocellular division of the PVN.
We were also able to demonstrate that tail-shock stress caused
an increase in AVP mRNA levels within CRH neurones. The






























































































































gene expression, suggesting a profound impact on HPA axisF. 3. Mean (±SEM) integrated optical density measurements of CRH
(), ENK () or NT () mRNA levels within the medial parvocellular regulation.
region of the PVN in control animals (n=7), and animals exposed to Previous observations that physically distinct stress para-
either yoked (n=7) or escapable (n=7) tail shock stress. ( ) illustrates digms led to differences in PVN mRNA expression, medianthe mean percentage of medial parvocellular digoxigenin-labelled CRH
eminence content and secretagogue release (8–12, 30–32) ledneurones that coexpress AVP mRNA in animals from the control and
stress groups. Asterisks indicate a significant difference (P∏0.05) from us to inquire whether psychologically distinct stressors also
control levels. cause dissimilar patterns of PVN activation. Additionally,
the observation that dexamethasone administration is not
equally effective in suppressing corticosterone secretion in the
an increase in the percentage of these neurones that also escapable vs yoked stress condition (22; unpublished observa-
expressed AVP mRNA. The increase in colocalization of tions) also suggested differences in HPA axis regulation
CRH and AVP mRNAs was similar in both the escapable between the two psychologically distinct stress conditions.
and yoked stress conditions, with 19±2.4% of CRH neurones Given the fact that the suppressing actions of dexamethasone
coexpressing AVP mRNA in the escapable stress group, and on ACTH and corticosterone secretion have been proposed
17±3.3% of CRH neurones coexpressing AVP mRNA in the to initially occur at the anterior pituitary (33), we hypothes-
yoked stress group. An example of a double-labelled neurone ized that one way the psychological variable of controllability
is illustrated is Fig. 4. could be communicated to the anterior pituitary was through
differential control of ACTH secretion by the PVN. Although
mRNA measurements are an indirect reflection of
secretagogue activity, the observed changes in mRNA within
the PVN suggest that the two stress conditions had similar
effects on the regulation of these peptides, suggesting that the
PVN is responding in a similar fashion to both types of
stressors. The similar changes in mpPVN mRNA measure-
ments between the two stress conditions also parallel the
similar changes in peripheral hormone measurements (i.e.
ACTH and corticosterone) caused by the two stress
conditions.
In the current study, we found that psychologically distinct
stressors do not stimulate different patterns of PVN mRNA
expression. It is important to note that the escapable vs yoked
tail-shock stress delivered in the manner used in the current
study does produce large behavioural and neurochemical
differences (34), thus making the failure to detect peptide
mRNA differences within the PVN more remarkable. The
similarities in stress-induced PVN mRNA changes between
the two stress conditions may be because strictly physical,
rather than psychological, characteristics of a stressor deter-
F. 4. Photomicrograph illustrating a digoxigenin-labelled CRH neur- mine the PVN mRNA response to that particular stimulus.one that coexpresses AVP mRNA (white arrow). A single labelled CRH
Therefore, because the physical stressor, tail-shock stress, wasneurone (black arrow) and an AVP magnocellular neurone (black
arrowhead) are also visible. Scale bar=20 mm. the same in both stress groups, one might predict that the
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PVN mRNA response would be similar in the two physically to maintain appropriate responsivity to a broad array of type
and duration of stressful stimuli (51, 52).similar, but psychologically dissimilar, stress groups. This is
not to suggest that psychological factors cannot influence the We also examined CRH mRNA levels within the CeA in
the current study. Given the observation that the CeA mayPVN mRNA response to stress; psychological attributes of
physically dissimilar stressors, such as cold vs restraint, may play a role in behavioural alterations observed after inescap-
able shock (53–55), and that administration of a CRHcontribute to the reported differences in stress-induced
mRNA changes within the PVN. antagonist into the CeA has been reported to decrease fear
associated behaviours, such as freezing (54, 55), that occurAlternatively, it may be that dissimilarities in PVN mRNA
expression that have been previously reported do not reflect after inescapable shock, we asked if escapable vs inescapable
shock may differentially alter CRH mRNA levels within thethe type of stress, but rather the magnitude of the stressor.
For example, when examining the increase in AVP levels CeA. Additionally, CRH mRNA levels in the CeA are
positively regulated by glucocorticoids; one might havewithin the median eminence after stress, Schmidt et al. (35)
reported that the increase in AVP levels was directly correl- expected that the increase in corticosterone levels observed
after stress would have caused an increase in CRH mRNAated with the ACTH response to the stressor, irrespective of
the stress stimulus used to activate the HPA axis. Also, we levels within the CeA. However, we found absolutely no
stress-induced changes in CRH mRNA levels after eitherhave found that PVN CRH and ENK mRNA levels are
significantly correlated with peak ACTH levels, occurring escapable or inescapable shock. CRH mRNA levels within
the CeA have been reported to increase if measured immedi-after either ether, restraint, or swim stress (unpublished
observations), again suggesting that the magnitude of the ately after the termination of the stressor (55, 56). In the
current study, we chose the 4 h post-stress termination timestress stimulus (as defined by changes in ACTH secretion) is
more closely linked to changes in mRNA levels within the to kill our animals in order to observe maximal changes in
PVN mRNAs (12). This may have prevented us fromPVN after stress rather than the physical attributes of the
stressor. Therefore, because escapable and yoked tail-shock detecting potentially very transient changes in CRH mRNA
levels within the CeA. It is also possible that circulatingstress stimulate similar levels of HPA axis activation (19, 20),
current results, unpublished data) we may not have expected corticosterone levels were not elevated long enough to cause
a change in CRH mRNA levels (50, 57). Alternatively, CRHto observe differences in pattern and magnitude of mRNA
expression within the PVN. mRNA containing neurones within the CeA may not respond
to tail-shock stress. In support of this hypothesis, we haveIt is also important to remember that this was an acute
exposure to the stress condition; it may be that repeated also found that CRH mRNA containing neurones within the
CeA do not respond to interleukin-1ß treatment, as indicatedexposure to the stress condition would lead to alterations of
the mpPVN response to the stressor. For example, repeated by the lack of colocalization of c-fos mRNA within these
neurones (58).exposure to restraint stress causes a greater AVP mRNA and
hnRNA response to acute stress, as compared to the response The use of controllable vs non-controllable stress paradigms
has proven to be a powerful paradigm to begin to understandmeasured in naive animals (36). Future experiments are
needed to determine whether repeated exposure to escapable how stressors alter the regulation of many systems within the
body, including the HPA axis, and to begin to explore theor yoked stress leads to difference in the magnitude, pattern,
or duration of mpPVN neuropeptide mRNA changes. powerful impact of psychological variables on the ultimate
effect of stressor on an organism. In ongoing studies, we areThe function of differential regulation of PVN mRNAs
across different stimuli is not clear. These peptides may serve beginning to use additional tools, such as examining changes
in c-fos mRNA, and examining additional circuits, such asdifferent functions in the regulation of the HPA axis. AVP is
known to be an ACTH secretagogue that can potentiate the 5-HT system, to learn more about how these psychologic-
ally distinct stressors impact the regulation of stress-relatedCRH effects at the level of the anterior pituitary (4).
Furthermore, CRH and AVP may alter their own release by systems within the central nervous system.
acting at the level of the hypothalamus (37, 38). NT has a
stimulatory effect on ACTH secretion that is dependent on
CRH. In contrast to AVP, NT does not have any measurable
Materials and methodseffect at the level of the pituitary; it may stimulate the HPA
axis by acting on receptors located within the hypothalamus Animals and experimental design
(39–41). ENK has been reported to have both stimulatory Twenty-eight adult male Sprague Dawley rats, b.w. 350–400 g, were used for
and inhibitory effects on ACTH and glucocorticoid secretion these studies. They were housed three to a cage with food and water available
ad libitum, and lights in the colony room were on from 07.00 to 19.00 hours.(42–47). The differential regulation of these peptides by
Animals were housed in the colony room for 2 weeks before the experiment.physically dissimilar stressors may reflect different afferent
Animals were randomly divided into four experimental groups (n=7/group);circuits used by stimuli to access the PVN (1). Also, glucocor-
Escapable Stress, Yoked Stress, Apparatus Control and Home Cage Control.
ticoids do not have similar effects on the regulation of The stress protocol was the same as that used in Grahn et al. (59). Briefly,
mRNAs for these peptides. For example, AVP appears to be animals from the escapable stress, yoked stress, and apparatus control groups
were placed in 14×11×17 cm wheel turning boxes. The wheel was two 14-cmexquisitely sensitive to glucocorticoid levels, while mRNA
disks connected by 9-cm rods. The wheels for the escapable stress groupslevels for NT and ENK are not altered by elimination of
turned easily, while those in the yoked and apparatus control group did not.circulating glucocorticoids (48–50). In sum, the differential Shock was administered to the escapable and yoked stress groups through
regulation of peptides within the PVN, both by stressors and electrodes fixed to the animals tail; the electrodes were placed 3 cm apart on
the distal part of the animal’s tail, augmented with electrode paste and heldglucocorticoids, has been proposed to enable the HPA axis
© 1999 Blackwell Science Ltd, Journal of Neuroendocrinology, 11, 121–128
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in place with tape. Shock was generated by a source modelled after a Grason- Double in-situ hybridization
Stadler model 700 shock generator (Quincy, MA, USA). To determine the number of CRH neurones containing AVP mRNA, we used
Each stress session consisted of 100 1.0 mA shocks delivered 30–90 s apart, a double in-situ hybridization protocol of Curran et al. (62), incorporating
with an average intertrial interval of 60 s. The duration of the shock for both some modifications from Watts et al. (52). CRH mRNA containing neurones
the escapable and yoked-stressed animal depended on the behaviour of the were detected using a digoxigenin (dig) labelled probe, transcribed using a
escapable stress animal. The shock was terminated after 30 s if the escape 20 ml transcription reaction containing 4 ml transcription buffer, 9 ml sterile
subject did not respond. At the beginning of the shock session, a quarter turn water, 2 ml NTP solution (containing 2 ml each of 10 mM ATP, GTP, and
of the wheel by the escape stress animal was required to terminate the shock. CTP, and 1.6 ml of 250 nmol dig-UTP (Boehringer Mannheim, Germany),
When three consecutive trials were completed in <5 s, the response require- and 0.4 ml of 10 mM UTP), 2 ml 0.1M dithiothreitol, 1 ml linearized
ment increased by a quarter turn on the next trial. Subsequent trials under DNA(1 mg/ml ), 1 ml RNase inhibitor, and 1 ml polymerase. AVP mRNA was
5 s duration were followed by a 50% increase in the response requirement detected using a (35S)-labelled 235 nt probe, generated as described above.
until the maximum response requirement of 16 quarter turns was achieved. Tissue sections were processed as previously described, except that the
If the subject failed to respond in <5 s, following any of these initial trials, proteinase K step was omitted. Thirty-five ml of hybridization buffer con-
the response requirement for the next trial decreased by a quarter turn. taining both the CRH and AVP probes was applied to each slide and sections
Response latencies of 30 s, indicating failure to respond, reset the requirement were coverslipped. Sections were hybridized and washed as described above;
to the initial quarter turn. after the 0.1×SSC wash at 65 °C the slides were placed in 0.1 M phosphate
Apparatus control groups were placed in the wheel turning chambers, but buffer (PB), pH 7.4. The slides were then transferred to a blocking solu-
they did not receive any tail shock (chamber group). Home cage controls tion(0.5% Triton X-100, 0.25% carageenan, 0.1 M PB) and incubated for 3 h
were kept in their home cages and removed only for the tail nick. at 30 °C. The sections were then transferred to fresh blocking solution which
A blood sample was collected (via tail nick) immediately after the termina- contained an alkaline phosphatase (AP)-conjugated antidig (sheep antidig-AP,
tion of the stress session(0 min) and at 30, 60, and 150 min after the Fab fragments; Boehringer Mannheim) at a 1520,000 dilution. Sections were
termination of the stress session. Animals were returned to their home cages incubated for 20 h at 4 °C. Slides were then washed twice with PB, pH 7.4,
after the stress session. The stress session was initiated at 08.30 h and typically twice with Tris-buffered saline, pH 7.5, and then transferred to alkaline
lasted 120 min. Animals were killed by decapitation 4 h post-termination of substrate buffer (ASB; 100 mM tris base, 150 mM NaCl, 50 mM MgCl2,the stress session. Brains were quickly removed and frozen, and trunk blood pH 9.5). The colour reaction was completed by placing the sections in ASB
was collected for measurement of circulating corticosterone levels. solution containing 5% polyvinyl alcohol (w:vol; Sigma, St Louis, MO, USA),
All procedures were in accordance with NIH guidelines and were approved 0.26% NBT(4-nitro blue tetrazolium chloride, Boehringer Mannheim),
by the University of Colorado Animal Care and Use Committee. 0.26% BCIP ( X-phosphate/5-bromo-4-chloro-3-indoyl-phosphate, Boehringer
Mannheim) and 0.024% levamisole (w:vol, Sigma). Slides were incubated in
In-situ hybridization this solution, in the dark, for 72 h at 4 °C, and then for 24 h at room
temperature. Slides were checked periodically throughout the incubationBrains were sectioned at 10 mm in the coronal plane, and sections were
collected onto poly-lysine subbed slides and were stored at −80 °C until period to monitor the progress of the colour reaction. After completion of
the colour reaction, slides were washed extensively with water, the Ab wasfurther processing. In-situ hybridization was conducted using techniques
previously described (60). Briefly, sections were removed from the freezer stripped by placing the slides in 0.1 M glycine solution, pH 2.2 for 10 min,
and then sections placed in a 2.5% gluteraldehyde solution for 60 min atand placed into cold 4% paraformaldehyde for 60 min. Following washes in
2×SSC, sections were deproteinated in 0.1 mg/ml proteinase K at 37 °C for room temperature. Slides were then washed extensively in water, and quickly
dehydrated through a series of alcohols. To visualize the (35S) signal, slides10 min, thoroughly rinsed with 2×SSC, and then were placed in 0.1 M
triethanolamine for 15 min to which 0.25% acetic anhydride had been added. were dipped in Ilford KD-5 emulsion (Polysciences, Warrington, PA, USA)
and exposed for 25 days at 4 °C. Slides were then developed and coverslippedSections were thoroughly washed with distilled water, and then dehydrated
through a series of graded alcohol. using Aqua-Poly/Mount (Polysciences, Inc., Warrington, PA, USA)
The 35S-labelled cRNA probes for CRH, ENK, and NT mRNA were
Radioimmunoassaygenerated using standard in-vitro transcription methodology. The rat CRH
cDNA clone (cDNA courtesy of R. C. Thompson) yielded a 770 nt probe, Plasma corticosterone concentrations were determined using a previously
described assay (63). Briefly, plasma was extracted by heating a 15100and the rat ENK cDNA clone yielded a 693 nt probe. NT mRNA levels were
detected using a 336 nt probe (cDNA courtesy of P. Dobner) directed against plasma: buffer dilution at 70 °C for 30 min. Antibody (no. 195 from our
laboratory) and 3H corticosterone (Amersham; Arlington Heights, IL, USA)exon 4 of the Neurotensin/Neuromedin gene (61). The probes were labelled
in a reaction mixture consisting of 1 mg of linearized plasmid, 1×transcription were added and allowed to incubate overnight. After incubation, bound trace
was separated from unbound trace using charcoal dextran. All samples werebuffer (Epicentre Technologies, Madison, WI, USA), 125 mCi (35S]UTP,
150 mM each of ATP, CTP and GTP, 12.5 mM dithiothreitol, 20 U RNase run in two assays, with the samples from different experimental groups
equally distributed between the two assays. Assay sensitivity was 1 pg/ml.inhibitor, and 6 U polymerase. The reaction was incubated for 60–90 min at
37 °C, treated with DNAase 1 for 15 min at room temperature, and then Intra-and interassay variability were 3.6% and 9.0%, respectively.
probe was separated from unincorporated nucleotides over a Sephadex
Data analysisG50–50 column. The probe was diluted in hybridization buffer to yield
#1.5×106 d.p.m./35 ml of buffer. Hybridization buffer was 50% formamide, For all analysis, the experimenter was blind to the experimental group of the
sections being analysed. For the single labelling studies, changes in mRNA10% dextran sulphate, 3×standard SSC, 50 mM sodium phosphate buffer
(pH 7.4), 1×Denharts solution, and 0.1 mg/ml yeast. Diluted probe (35 ml ) levels were determined using the public domain NIH Image software (written
by Wayne Rasband at the NIH; version 1.6) on a Power Macintosh 8100/80was applied to each slide and sections were coverslipped. Slides were placed
in sealed plastic boxes lined with filter paper moistened with 50% formamide. AV computer. Relative optical density was determined for the area of interest
from the X-ray film; positive signal was considered to be optical density levelsThese boxes were wrapped with plastic wrap and incubated at 55 °C for 16 h.
Coverslips were removed, and slides were washed in 2×SSC. Slides were then above a threshold level which was 3 SD above the mean optical density of
the background signal. Values reflect integrated optical density, which incorp-incubated in RNase A (200 mg/ml ) at 37 °C for 60 min, washed successively
in decreasing concentrations of SSC (2×, 1×, 0.5×, 0.1×) and then washed orates both the intensity and area of positive signal. CRH, ENK, and NT
mRNA levels were each determined from three sections localized in thein 0.1×SSC at 65 °C for 60 min. Slides were subsequently washed in distilled
water and dehydrated through graded alcohol. Slides were then exposed to middle regions of the PVN, where the highest levels of CRH mRNA are
detected (64).BioMax film (Eastman Kodak, Rochester, NY, USA) for 6 h (ENK), 1 day
(CRH) or 11 days (NT). Slides were then dipped in NTB2 emulsion (diluted CRH mRNA levels within the central nucleus of the amygdala (CeA) were
also determined. Integrated optical density measurements were determined1:1; Eastman Kodak, Rochester, NY, USA) and stored at 4 °C for 1 day
(ENK) or 4 weeks (CRH and NT). Emulsion dipped slides, used for from three sections showing the highest CRH mRNA levels within this region.
For the double labelling studies, emulsion-dipped sections were examinedphotographic purposes, were developed in D-19 developer (Eastman Kodak,
Rochester, NY, USA), counterstained with cresyl violet, dehydrated in graded using a Leica DMR microscope. Initially, the number of neurones containing
dig-labelled CRH mRNA was determined. These neurones were determinedseries of alcohol, placed in xylene, and coverslipped with Permount (Fisher
Scientific, Pittsburgh, PA, USA). To allow reliable comparisons between to contain AVP mRNA if there was a distinct clustering of silver grains,
above background levels, that was centred over a positive CRH neurone.groups, sections from each group were processed together.
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Statistical analysis after inescapable and escapable pre-shock in rats. Scan J Psychol. 1982;
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ship to norepeinephrine, dopamine, and serotonin levels in variousfollowed by Fisher PLSD post-hoc tests. Significant differences among plasma
regions of rat brain. Brain Res Rev 1981; 3: 167–205.corticosterone values were determined using a repeated-measures anova,
17 Shors T, Seib T, Levine S, Thompson R. Inescapable versus escapablefollowed by Scheffe post-hoc tests. Significance was P∏0.05. Additionally, for
shock modulates long-term potentiation in the rat hippocampus. Scienceall mRNA analysis, the chamber control groups group values were not
1989; 244: 224–226.significantly different from home cage control, so for reasons of clarity only
18 Seligman M, Weiss J. Coping Behavior: Learned helplessness, physiologi-data from home cage controls is illustrated.
cal change, and learned activity. Behav Res Ther 1980; 18: 459–512.
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